Honasa Consumer acquired a 58% stake in Fluence Pharma, marking its entry into the ₹16,000 crore nutraceuticals market. Fluence Pharma reported FY26 revenue of approximately ₹40 crore with EBITDA margins exceeding 20%. The company will establish Honasa Health Private Limited to build a consumer-focused nutraceuticals franchise and expand beyond traditional beauty products. (55 words)